Cite
HARVARD Citation
Firl, D. et al. (2020). Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4, 089 Patients. Hepatology. 71 (2), pp. 569-582. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Firl, D. et al. (2020). Charting the Path Forward for Risk Prediction in Liver Transplant for Hepatocellular Carcinoma: International Validation of HALTHCC Among 4, 089 Patients. Hepatology. 71 (2), pp. 569-582. [Online].